Aimm Therapeutics aimmtherapeutics.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

AIMM is a biotech company spun-out of the Netherlands Cancer Institute and the Academic Medical Center at the University of Amsterdam. The company aims to develop high quality human monoclonal antibodies to treat diseases with a high, unmet medical need. AIMM exploits and develops new, innovative technologies to generate stable monoclonal cell lines of human antibody-producing B cells against infectious agents.

AIMM is a biotech company spun-out of the Netherlands Cancer Institute and the Academic Medical Center at the University of Amsterdam. The company aims to develop high quality human monoclonal antibodies to treat diseases with a high, unmet medical n...Show all

Company (Alive / Active)

Phone:

Fax:




Netherlands

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Aimm Therapeutics $0M Jun 5, 2009

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Aimm Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Life Sciences Fund AmsterdamVenture CapitalNetherlandsUnattributed VC
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Means and methods for producing high affinity antibodies Dec 02, 2015 May 15, 2018 Patent
Gram-positive bacteria specific binding compounds Aug 24, 2016 Mar 27, 2018 Patent
Means and methods for influencing the stability of antibody producing cells Aug 26, 2015 Nov 21, 2017 Patent
Influenza a virus specific antibodies Dec 03, 2012 Aug 01, 2017 Patent
Rsv g protein specific antibodies Nov 16, 2012 Aug 01, 2017 Patent
See all 24 patents